Codelivery of doxorubicin and triptolide with reduction-sensitive lipid–polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment

Codelivery is a promising strategy to overcome the limitations of single chemotherapeutic agents in cancer treatment. Despite progress, codelivery of two or more different functional drugs to increase anticancer efficiency still remains a challenge. Here, reduction-sensitive lipid–polymer hybrid nan...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Nanomedicine
Main Authors: Wu, Bo, Lu, Shu-Ting, Zhang, Liu-Jie, Zhuo, Ren-Xi, Xu, Hai-Bo, Huang, Shi-Wen
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2017
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5352248/
https://ncbi.nlm.nih.gov/pubmed/28331310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S131235
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki